Clinical Trial: Real-World Clinical Outcomes in Relapsed/Refractory Multiple Myeloma Treated With Pomalidomide Regimens

U.S., July 8 -- ClinicalTrials.gov registry received information related to the study (NCT07689006) titled 'Real-World Clinical Outcomes in Relapsed/Refractory Multiple Myeloma Treated With Pomalidomide Regimens' on June 30.

Brief Summary: This retrospective observational study will use data from the OneOncology United States database to evaluate clinical outcomes in adults with relapsed/refractory multiple myeloma who received pomalidomide-containing or non-pomalidomide-containing treatment as second-line or third-line therapy after prior exposure to lenalidomide and a proteasome inhibitor.

Study Start Date: Dec. 23, 2024

Study Type: OBSERVATIONAL

Condition: Relapsed/Refractory Multiple Myeloma

Intervention: DRUG: Pomalidomide-conta...